Taipei Exchange - Delayed Quote TWD

Bioteque Corporation (4107.TWO)

120.50
-1.00
(-0.82%)
At close: 1:30:40 PM GMT+8
Currency in TWD All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
2,094,877
2,072,575
1,944,701
2,010,272
1,825,491
Cost of Revenue
1,170,310
1,167,497
1,125,764
1,165,730
1,022,622
Gross Profit
924,567
905,078
818,937
844,542
802,869
Operating Expense
262,775
261,908
238,761
266,166
254,941
Operating Income
661,792
643,170
580,176
578,376
547,928
Net Non Operating Interest Income Expense
5,157
4,158
-635
-2,182
-1,168
Pretax Income
689,649
678,368
569,515
623,179
538,197
Tax Provision
152,542
150,108
116,965
129,639
106,940
Net Income Common Stockholders
537,107
528,260
452,550
493,540
431,257
Diluted NI Available to Com Stockholders
537,107
528,260
452,550
493,540
431,257
Basic EPS
7.75
7.62
6.53
7.12
6.22
Diluted EPS
7.71
7.59
6.50
7.09
6.20
Basic Average Shares
69,274.78
69,298
69,298
69,298
69,298
Diluted Average Shares
69,699.61
69,633
69,624
69,647
69,600
Total Expenses
1,433,085
1,429,405
1,364,525
1,431,896
1,277,563
Net Income from Continuing & Discontinued Operation
537,107
528,260
452,550
493,540
431,257
Normalized Income
537,107
528,260
452,550
493,540
431,257
Interest Income
13,958
13,529
10,968
2,137
729
Interest Expense
8,801
9,371
11,603
4,319
1,897
Net Interest Income
5,157
4,158
-635
-2,182
-1,168
EBIT
698,450
687,739
581,118
627,498
540,094
EBITDA
864,571
850,597
737,078
759,126
662,297
Reconciled Cost of Revenue
1,170,310
1,167,497
1,125,764
1,165,730
1,022,622
Reconciled Depreciation
166,121
162,858
155,960
131,628
122,203
Net Income from Continuing Operation Net Minority Interest
537,107
528,260
452,550
493,540
431,257
Total Unusual Items Excluding Goodwill
0
0
0
0
0
Total Unusual Items
0
0
0
0
0
Normalized EBITDA
864,571
850,597
737,078
759,126
662,297
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 12/31/2007

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers